CSR through Business Activities

The national cost of medical care continues to grow along with the rapid advancement of an aging society. Sawai Pharmaceutical contributes to the reduction of national medical care costs through the supply of lower-cost drugs that are as therapeutically effective as original drugs.In fiscal 2017, ended March 31, 2018, we contributed to the reduction of medical care expenditures by about 275 billion yen.
※Domestic market, estimated by the Company
Reduction in Medeical Expenses
About CSR
Message from the CSR Committee Chairperson
CSR Basic Policies
Approach to CSR
Integrated Report
CSR through Business Activities
ESG data
Back to Top